Core Viewpoint - Qianhai Health (00911.HK) expects to record a profit attributable to shareholders ranging from HKD 5 million to HKD 6 million for the year ending December 31, 2025, compared to approximately HKD 1.3 million for the year ending December 31, 2024, indicating a significant improvement in net profit due to the absence of loss contract provisions in the fiscal year [1] Financial Performance - The expected profit for the year ending December 31, 2025, is projected to be between HKD 5 million and HKD 6 million [1] - The profit attributable to shareholders for the year ending December 31, 2024, is approximately HKD 1.3 million [1] - The improvement in consolidated net profit is primarily attributed to the lack of loss contract provisions in the fiscal year [1]
前海健康(00911.HK)盈喜：预计录得年度股东应占溢利500万港元-600万港元